Biotech · Public company · Woburn, MA, US

Biofrontera Inc.

Ticker BFRI · SEC CIK 0001858685

Track this companyFree. Adds Biofrontera Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials51 recruiting or active

Pipeline programs7From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline7

BF-200 ALA and red light LED lampPhase 3 · Actinic KeratosesClinicalTrials.gov · fetched Nov 12, 2026
Photodynamic therapy (PDT) (ALA-PDT, Ameluz®-PDT)Phase 3 · Superficial Basal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Vehicle and red light LED lampPhase 3 · Actinic KeratosesClinicalTrials.gov · fetched Nov 12, 2026
1h Incubation Photodynamic therapy (PDT) (ALA-PDT, Ameluz®-PDT)Phase 2 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
1h Incubation Photodynamic therapy (PDT) (vehicle to BF-200 ALA containing no active ingredient)Phase 2 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
3h Incubation Photodynamic therapy (PDT) (ALA-PDT, Ameluz®-PDT)Phase 2 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026
3h Incubation Photodynamic therapy (PDT) (vehicle to BF-200 ALA containing no active ingredient)Phase 2 · Acne VulgarisClinicalTrials.gov · fetched Nov 12, 2026

Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)PHASE2 · UNKNOWN · started Aug 14, 2024ClinicalTrials.gov NCT06577311 · fetched Nov 12, 2026
Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic KeratosesPHASE2 · COMPLETED · started Oct 2, 2023ClinicalTrials.gov NCT06027619 · fetched Nov 12, 2026
Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED LampPHASE3 · COMPLETED · started Dec 12, 2022ClinicalTrials.gov NCT05662202 · fetched Nov 12, 2026
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in AdultsPHASE2 · COMPLETED · started Dec 10, 2021ClinicalTrials.gov NCT05080764 · fetched Nov 12, 2026
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).PHASE3 · ACTIVE_NOT_RECRUITING · started Sep 25, 2018ClinicalTrials.gov NCT03573401 · fetched Nov 12, 2026